ZA200503756B - Positional isomers of PEG IFN alpha 2a - Google Patents
Positional isomers of PEG IFN alpha 2aInfo
- Publication number
- ZA200503756B ZA200503756B ZA200503756A ZA200503756A ZA200503756B ZA 200503756 B ZA200503756 B ZA 200503756B ZA 200503756 A ZA200503756 A ZA 200503756A ZA 200503756 A ZA200503756 A ZA 200503756A ZA 200503756 B ZA200503756 B ZA 200503756B
- Authority
- ZA
- South Africa
- Prior art keywords
- positional isomers
- ifn alpha
- peg ifn
- peg
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02025585 | 2002-11-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200503756B true ZA200503756B (en) | 2008-02-27 |
Family
ID=32319537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200503756A ZA200503756B (en) | 2002-11-15 | 2005-05-10 | Positional isomers of PEG IFN alpha 2a |
Country Status (23)
Country | Link |
---|---|
US (1) | US20040223950A1 (no) |
EP (1) | EP1562634B1 (no) |
JP (1) | JP4279258B2 (no) |
KR (1) | KR20050065677A (no) |
CN (1) | CN1323722C (no) |
AR (1) | AR042039A1 (no) |
AT (1) | ATE337017T1 (no) |
AU (1) | AU2003293668A1 (no) |
BR (1) | BR0316227A (no) |
CA (1) | CA2503594C (no) |
DE (1) | DE60307881T2 (no) |
ES (1) | ES2270152T3 (no) |
GT (1) | GT200300244A (no) |
MX (1) | MXPA05005178A (no) |
NO (1) | NO20052310L (no) |
PA (1) | PA8587801A1 (no) |
PE (1) | PE20040834A1 (no) |
PL (1) | PL376883A1 (no) |
RU (1) | RU2005118752A (no) |
TW (1) | TW200413404A (no) |
UY (1) | UY28080A1 (no) |
WO (1) | WO2004045648A1 (no) |
ZA (1) | ZA200503756B (no) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0316324A (pt) * | 2002-11-18 | 2005-09-27 | Maxygen Inc | Polipeptìdeos e conjugados de interferon-alfa |
US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
AU2008201682B2 (en) * | 2004-02-02 | 2011-02-24 | Ambrx, Inc. | Modified human interferon polypeptides and their uses |
KR20070007086A (ko) | 2004-02-02 | 2007-01-12 | 암브룩스, 인코포레이티드 | 변형된 인간의 4 개의 나선형 다발 폴리펩티드 및 이의용도 |
CN101115769A (zh) | 2004-05-19 | 2008-01-30 | 马克西根公司 | 干扰素-α多肽和偶联物 |
MX2007014524A (es) | 2005-05-18 | 2008-02-07 | Maxygen Inc | Polipeptidos desarrollados de interferon-alfa. |
US7695710B2 (en) | 2005-06-20 | 2010-04-13 | Pepgen Corporation | Antitumor and antiviral combination therapies using low-toxicity, long-circulating human interferon-alpha analogs |
WO2007002233A2 (en) * | 2005-06-20 | 2007-01-04 | Pepgen Corporation | Low-toxicity, long-circulating chimeras of human interferon- alpha analogs and interferon tau |
CN101002944B (zh) * | 2006-01-17 | 2012-07-25 | 中国科学院过程工程研究所 | 支链聚乙二醇-干扰素结合物及其制备方法 |
AR078117A1 (es) * | 2006-06-20 | 2011-10-19 | Protech Pharma S A | Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina |
BRPI0721988B1 (pt) * | 2007-09-04 | 2021-07-27 | Biosteed Gene Expression Tech. Co., Ltd | Interferon alfa 2a modificado por polietileno glicol, método para preparação e uso do mesmo, e composição. |
RU2485134C2 (ru) * | 2007-09-04 | 2013-06-20 | Биостид Джене Експрешен Тек. Ко., Лтд. | Интерферон альфа 2в, модифицированный полиэтиленгликолем, получение препарата и его применение |
AU2008353850B2 (en) * | 2008-04-03 | 2014-08-21 | Biosteed Gene Expression Tech. Co., Ltd. | Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
EP2113256A1 (en) | 2008-04-29 | 2009-11-04 | Ascendis Pharma AS | PEGylated rhGH compounds |
CA2915677C (en) | 2008-04-29 | 2018-06-26 | Ascendis Pharma Growth Disorders Division A/S | Pegylated recombinant human growth hormone compounds |
DE102009009344B4 (de) * | 2009-02-05 | 2018-01-04 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | Verfahren und Anordnung zur Reinigung des Reaktionsgemisches bei der Herstellung von Radiopharmaka |
WO2010110503A1 (ko) * | 2009-03-27 | 2010-09-30 | 주식회사 중외제약 | 인터페론-알파 및 세포질 잔류성 세포막 투과 펩타이드를 포함하는 IFN-α 융합 단백질 |
CN101514229B (zh) * | 2009-04-03 | 2012-05-09 | 海南四环心脑血管药物研究院有限公司 | 人干扰素α衍生物及其聚乙二醇化修饰物 |
PT3220892T (pt) | 2014-11-21 | 2021-11-05 | Ascendis Pharma Endocrinology Div A/S | Formas de dosagem de hormona do crescimento de longa ação |
CN106749608B (zh) * | 2015-11-18 | 2021-10-15 | 石药集团中奇制药技术(石家庄)有限公司 | 干扰素α缀合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5951974A (en) * | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
CA2497777A1 (en) * | 2002-09-05 | 2004-03-18 | The General Hospital Corporation | Modified asialo-interferons and uses thereof |
-
2003
- 2003-11-10 JP JP2004552547A patent/JP4279258B2/ja not_active Expired - Lifetime
- 2003-11-10 MX MXPA05005178A patent/MXPA05005178A/es unknown
- 2003-11-10 ES ES03789020T patent/ES2270152T3/es not_active Expired - Lifetime
- 2003-11-10 AT AT03789020T patent/ATE337017T1/de not_active IP Right Cessation
- 2003-11-10 CN CNB2003801033411A patent/CN1323722C/zh not_active Expired - Lifetime
- 2003-11-10 EP EP03789020A patent/EP1562634B1/en not_active Expired - Lifetime
- 2003-11-10 PL PL376883A patent/PL376883A1/pl not_active Application Discontinuation
- 2003-11-10 WO PCT/EP2003/012498 patent/WO2004045648A1/en active IP Right Grant
- 2003-11-10 KR KR1020057008685A patent/KR20050065677A/ko not_active Application Discontinuation
- 2003-11-10 RU RU2005118752/04A patent/RU2005118752A/ru not_active Application Discontinuation
- 2003-11-10 AU AU2003293668A patent/AU2003293668A1/en not_active Abandoned
- 2003-11-10 DE DE60307881T patent/DE60307881T2/de not_active Expired - Lifetime
- 2003-11-10 BR BR0316227-3A patent/BR0316227A/pt not_active Application Discontinuation
- 2003-11-10 CA CA2503594A patent/CA2503594C/en not_active Expired - Fee Related
- 2003-11-12 PA PA20038587801A patent/PA8587801A1/es unknown
- 2003-11-12 TW TW092131686A patent/TW200413404A/zh unknown
- 2003-11-13 GT GT200300244A patent/GT200300244A/es unknown
- 2003-11-13 AR ARP030104175A patent/AR042039A1/es unknown
- 2003-11-13 US US10/712,494 patent/US20040223950A1/en not_active Abandoned
- 2003-11-13 PE PE2003001148A patent/PE20040834A1/es not_active Application Discontinuation
- 2003-11-13 UY UY28080A patent/UY28080A1/es not_active Application Discontinuation
-
2005
- 2005-05-10 ZA ZA200503756A patent/ZA200503756B/xx unknown
- 2005-05-11 NO NO20052310A patent/NO20052310L/no unknown
Also Published As
Publication number | Publication date |
---|---|
ES2270152T3 (es) | 2007-04-01 |
EP1562634A1 (en) | 2005-08-17 |
DE60307881T2 (de) | 2007-03-08 |
JP2006515571A (ja) | 2006-06-01 |
UY28080A1 (es) | 2004-05-31 |
PL376883A1 (pl) | 2006-01-09 |
AU2003293668A1 (en) | 2004-06-15 |
RU2005118752A (ru) | 2006-02-10 |
EP1562634B1 (en) | 2006-08-23 |
AR042039A1 (es) | 2005-06-08 |
KR20050065677A (ko) | 2005-06-29 |
PE20040834A1 (es) | 2004-11-17 |
GT200300244A (es) | 2004-06-03 |
CA2503594A1 (en) | 2004-06-03 |
NO20052310L (no) | 2005-08-09 |
CA2503594C (en) | 2011-05-10 |
BR0316227A (pt) | 2005-10-04 |
CN1323722C (zh) | 2007-07-04 |
ATE337017T1 (de) | 2006-09-15 |
MXPA05005178A (es) | 2005-07-22 |
TW200413404A (en) | 2004-08-01 |
CN1711109A (zh) | 2005-12-21 |
DE60307881D1 (de) | 2006-10-05 |
NO20052310D0 (no) | 2005-05-11 |
WO2004045648A1 (en) | 2004-06-03 |
US20040223950A1 (en) | 2004-11-11 |
JP4279258B2 (ja) | 2009-06-17 |
PA8587801A1 (es) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200503756B (en) | Positional isomers of PEG IFN alpha 2a | |
AU2003259949A8 (en) | Face mask support | |
HUP0303732A2 (en) | Hsa-free formulations of interferon-beta | |
PL375833A1 (en) | Pharmaceutical formulations of modafinil | |
HK1083762A1 (en) | Analogues of glp-1 | |
HK1078265A1 (en) | Novel pharmaceutical formulations of modafinil | |
PL375784A1 (en) | Use of erythopoietin | |
GB0202900D0 (en) | Novel formulations of drugs | |
IL165691A0 (en) | Epimerization of analogs of vitamin D | |
AU2003302320A8 (en) | Seterocyclic quinones as pharmaceutical agents | |
AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
PL373284A1 (en) | Analogues of vitamin d | |
AU2003276470A8 (en) | Alpha macroglobulin family member | |
TW535585U (en) | Structure of love-playing chair | |
TW533806U (en) | Structure of improved-type chair | |
TW579826U (en) | Structure of retainer | |
TW552949U (en) | Improved structure of mask | |
TW525447U (en) | Structure of table | |
IL165356A0 (en) | Preparation of 4-haloalkylkylnicotinamides | |
SI1537065T1 (sl) | Analogi D vitamina | |
AU2003272534A8 (en) | Therapeutic uses of linear ketophosphonates | |
TW566215U (en) | Structure of base of skateboard | |
TW541915U (en) | Structure improvement of chair | |
TW567775U (en) | Structure of hairtie | |
AU151765S (en) | Set of tables |